Adverum Biotechnologies (ADVM)
(Delayed Data from NSDQ)
$5.39 USD
+0.12 (2.28%)
Updated Oct 3, 2025 04:00 PM ET
After-Market: $5.55 +0.16 (2.97%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ADVM 5.39 +0.12(2.28%)
Will ADVM be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for ADVM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ADVM
Adverum Biotechnologies (ADVM) Reports Q3 Loss, Tops Revenue Estimates
Adverum Biotechnologies (ADVM) Upgraded to Strong Buy: What Does It Mean for the Stock?
ADVM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ADVM
ADVM forms NR7 on October 3
Stochastic Reached Overbought appears for ADVM after 7.98% move
Upper Bollinger Band Walk appears for ADVM after 10.6% move
Is ADVM set to rally? Upper Bollinger Band Walk shows up after declining 1.52%
ADVM forms Upper Bollinger Band Walk on September 29